Trials for a pancreatic cancer mRNA vaccine: “Nearly 90% of people whose immune systems responded to the vaccine were still alive up to six years after receiving the last treatment. The five-year survival rate for pancreatic cancer is around 13%…”.
Trials for a pancreatic cancer mRNA vaccine :...
Continue Reading on Kottke.org
This article continues with additional insights and analysis. Read the full article for free.
Read Full Article on Kottke.org